| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2013 | US8354445 Inhibitors of histone deacetylase |
| 01/15/2013 | US8354444 Substituted pyrrolidine-2-carboxamides |
| 01/15/2013 | US8354443 Cyclopropane indolinone derivatives |
| 01/15/2013 | US8354442 Imidazol-4-one and imidazole-4-thione compounds |
| 01/15/2013 | US8354441 Oxazoline derivatives |
| 01/15/2013 | US8354440 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/15/2013 | US8354439 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 01/15/2013 | US8354438 Neurological functions |
| 01/15/2013 | US8354437 Method of using sustained release aminopyridine compositions |
| 01/15/2013 | US8354436 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation |
| 01/15/2013 | US8354435 Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| 01/15/2013 | US8354434 Cyclourea compounds as calcium channel blockers |
| 01/15/2013 | US8354433 Anti-inflammatory agents as virostatic compounds |
| 01/15/2013 | US8354432 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/15/2013 | US8354431 Aryl carboxylic acid cyclohexyl amide derivatives |
| 01/15/2013 | US8354430 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine |
| 01/15/2013 | US8354429 Inhibitors of human immunodeficiency virus replication |
| 01/15/2013 | US8354428 Solid state forms of laquinimod and its sodium salt |
| 01/15/2013 | US8354427 Modulators of ATP-binding cassette transporters |
| 01/15/2013 | US8354426 Naphthyridine derivative monohydrate and method for producing the same |
| 01/15/2013 | US8354425 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | US8354424 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; applying topically to an actinic keratosis lesion twice per week for a duration of 8 weeks |
| 01/15/2013 | US8354423 Insecticidal spironindane derivatives |
| 01/15/2013 | US8354422 Pyrimidine inhibitors of kinase activity |
| 01/15/2013 | US8354421 HIV reverse transcriptase inhibitors |
| 01/15/2013 | US8354420 Aminopyrimidine derivatives as LRRK2 inhibitors |
| 01/15/2013 | US8354419 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 01/15/2013 | US8354418 Thiazolyl-dihydro-quinazolines |
| 01/15/2013 | US8354417 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 01/15/2013 | US8354416 3-[2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-5-fluoro-4-methyl-N-(1-methylethyl)benzamide; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs; mitogen-activated protein kinase inhibitors |
| 01/15/2013 | US8354415 Thienopyrimidine compounds and compositions |
| 01/15/2013 | US8354414 Substituted bicyclic pyrimidines |
| 01/15/2013 | US8354413 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 01/15/2013 | US8354412 Beta-3 receptor ligands and their use in therapy |
| 01/15/2013 | US8354411 1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound |
| 01/15/2013 | US8354410 Compounds for the treatment of hepatitis C |
| 01/15/2013 | US8354409 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/15/2013 | US8354408 N-containing heterocyclic compounds |
| 01/15/2013 | US8354407 2-anilino-4-(heterocyclic)amino-pyrimidines |
| 01/15/2013 | US8354406 Chemical compounds |
| 01/15/2013 | US8354405 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | US8354404 Apoptosis promoters |
| 01/15/2013 | US8354403 Pyrrolidine derived beta 3 adrenergic receptor agonists |
| 01/15/2013 | US8354402 Polyarylcarboxamides useful as lipid lowering agents |
| 01/15/2013 | US8354401 Oxazolidinone amide aromatic compounds for supressing MMP-9 production |
| 01/15/2013 | US8354400 Benzoxazole compounds and methods of use |
| 01/15/2013 | US8354399 Substituted indazole derivatives active as kinase inhibitors |
| 01/15/2013 | US8354398 Substituted isoxazole compounds |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | US8354396 Identifying compounds that can treat autoimmune conditions; ulcerative colitis, inflammatory bowel disease, Crohn's disease, psoriasis, actinic keratosis, arthritis, multiple sclerosis, optic neuritis |
| 01/15/2013 | US8354395 Method for providing neuroprotection from spinal muscular atrophy |
| 01/15/2013 | US8354394 Diuretics |
| 01/15/2013 | US8354393 Film preparation and process for preparing the same |
| 01/15/2013 | US8354392 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 01/15/2013 | US8354390 Compositions and methods for inhibiting expression of a gene from the ebola virus |
| 01/15/2013 | US8354383 6,11-bridged biaryl macrolides |
| 01/15/2013 | US8354382 Hemifumarate of a pyrazole derivative |
| 01/15/2013 | US8354225 Amplification of oligonucleotides containing non-standard nucleobases |
| 01/15/2013 | US8354129 Vitamin containing product |
| 01/15/2013 | US8354127 Structure and bioactivity of the polysaccharides and oligomers in medicinal plant Dendrobium huoshanense |
| 01/15/2013 | US8354124 Oral drug delivery system |
| 01/15/2013 | US8354121 Tape preparation |
| 01/15/2013 | US8354095 biodegradable drug delivery system; fungal infection; inflammation; injection |
| 01/15/2013 | DE202012011337U1 Arzneimittel gegen Krebs, Herzinfarkt und Tuberkulose sowie gegen sämtliche Krankheiten Medicines to treat cancer, heart attack and tuberculosis, and treat all diseases |
| 01/15/2013 | CA2753345C 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same |
| 01/15/2013 | CA2712821C Use of oxidase inhibitor with dextromethorphan to treat intractable coughing and dermatitis |
| 01/15/2013 | CA2706833C Geranyl compounds |
| 01/15/2013 | CA2706826C Geranyl compounds |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2693997C Viral polymerase inhibitors |
| 01/15/2013 | CA2689092C Raf kinase modulators and methods of use |
| 01/15/2013 | CA2677095C Improved reduced irritant enema for the treatment of inflammatory bowel disease (ibd) |
| 01/15/2013 | CA2650577C Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation |
| 01/15/2013 | CA2627790C Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 01/15/2013 | CA2597016C Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 01/15/2013 | CA2589479C Osmotic device containing amantadine and an osmotic salt |
| 01/15/2013 | CA2587283C S-mirtazapine for the treatment of hot flush |
| 01/15/2013 | CA2583375C Regulation of oncogenes by micrornas |
| 01/15/2013 | CA2574664C Compound formulations of 2-amino-1,3-propanediol compounds |
| 01/15/2013 | CA2572971C Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 01/15/2013 | CA2571742C Canine osteoarthritis diet formulation |
| 01/15/2013 | CA2570524C High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms |
| 01/15/2013 | CA2570042C Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof |
| 01/15/2013 | CA2567831C N-sulfonylcarboximidamide apoptosis promoters |
| 01/15/2013 | CA2565431C Antibiotic compound produced by fermentation with streptomyces sp. |
| 01/15/2013 | CA2563830C Transdermal steroid formulation |
| 01/15/2013 | CA2561873C An alginate oligosaccharide and its derivatives, and the preparation and uses thereof |
| 01/15/2013 | CA2560253C Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/15/2013 | CA2558254C Cream-gel containing ivermectin |
| 01/15/2013 | CA2556459C Extended cycle multiphasic oral contraceptive method |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/15/2013 | CA2538202C Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 01/15/2013 | CA2524161C Pyridinyl acetonitriles |
| 01/15/2013 | CA2503373C Composition for enhancing physical performance |
| 01/15/2013 | CA2483817C Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/15/2013 | CA2443323C Nucleic acid vaccines for prevention of flavivirus infection |
| 01/15/2013 | CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 01/15/2013 | CA2427774C Inhibitors of thromboxane formation and action |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/15/2013 | CA2346131C Method for improving the pharmacokinetics of tipranavir |